Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles

James O. Park, Zachary Stephen, Conroy Sun, Omid Veiseh, Forrest M. Kievit, Chen Fang, Matthew Leung, Hyejung Mok, Miqin Zhang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Imaging is essential in accurately detecting, staging, and treating primary liver cancer (hepatocellular carcinoma [HCC]), one of the most prevalent and lethal malignancies. We developed a novel multifunctional nanoparticle (NP) specifically targeting glypican-3 (GPC3), a proteoglycan implicated in promotion of cell growth that is overexpressed in most HCCs. Quantitative real-time polymerase chain reaction was performed to confirm the differential GPC3 expression in two human HCC cells, Hep G2 (high) and HLF (negligible). These cells were treated with biotin-conjugated GPC3 monoclonal antibody (αGPC3) and subsequently targeted using superparamagnetic iron oxide NPs conjugated to streptavidin and Alexa Fluor 647. Flow cytometry demonstrated that only GPC3-expressing Hep G2 cells were specifically targeted using this αGPC3-NP conjugate (fourfold mean fluorescence over nontargeted NP), and magnetic resonance imaging (MRI) experiments showed similar findings (threefold R2 relaxivity). Confocal fluorescence microscopy localized the αGPC3 NPs only to the cell surface of GPC3-expressing Hep G2 cells. Further characterization of this construct demonstrated a negatively charged, monodisperse, 50 nm NP, ideally suited for tumor targeting. This GPC3-specific NP system, with dual-modality imaging capability, may enhance pretreatment MRI, enable refined intraoperative HCC visualization by near-infrared fluorescence, and be potentially used as a carrier for delivery of tumor-targeted therapies, improving patient outcomes.

Original languageEnglish (US)
Pages (from-to)69-77
Number of pages9
JournalMolecular Imaging
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Glypicans
Liver Neoplasms
liver
Liver
Nanoparticles
cancer
Cells
nanoparticles
Imaging techniques
cells
Magnetic resonance
fluorescence
Hep G2 Cells
magnetic resonance
Tumors
tumors
Fluorescence
Hepatocellular Carcinoma
polymerase chain reaction
biotin

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging
  • Condensed Matter Physics

Cite this

Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles. / Park, James O.; Stephen, Zachary; Sun, Conroy; Veiseh, Omid; Kievit, Forrest M.; Fang, Chen; Leung, Matthew; Mok, Hyejung; Zhang, Miqin.

In: Molecular Imaging, Vol. 10, No. 1, 01.01.2011, p. 69-77.

Research output: Contribution to journalArticle

Park, JO, Stephen, Z, Sun, C, Veiseh, O, Kievit, FM, Fang, C, Leung, M, Mok, H & Zhang, M 2011, 'Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles', Molecular Imaging, vol. 10, no. 1, pp. 69-77. https://doi.org/10.2310/7290.2010.00048
Park, James O. ; Stephen, Zachary ; Sun, Conroy ; Veiseh, Omid ; Kievit, Forrest M. ; Fang, Chen ; Leung, Matthew ; Mok, Hyejung ; Zhang, Miqin. / Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles. In: Molecular Imaging. 2011 ; Vol. 10, No. 1. pp. 69-77.
@article{2ed1f25c33ac4f6591ede4cddbf80517,
title = "Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles",
abstract = "Imaging is essential in accurately detecting, staging, and treating primary liver cancer (hepatocellular carcinoma [HCC]), one of the most prevalent and lethal malignancies. We developed a novel multifunctional nanoparticle (NP) specifically targeting glypican-3 (GPC3), a proteoglycan implicated in promotion of cell growth that is overexpressed in most HCCs. Quantitative real-time polymerase chain reaction was performed to confirm the differential GPC3 expression in two human HCC cells, Hep G2 (high) and HLF (negligible). These cells were treated with biotin-conjugated GPC3 monoclonal antibody (αGPC3) and subsequently targeted using superparamagnetic iron oxide NPs conjugated to streptavidin and Alexa Fluor 647. Flow cytometry demonstrated that only GPC3-expressing Hep G2 cells were specifically targeted using this αGPC3-NP conjugate (fourfold mean fluorescence over nontargeted NP), and magnetic resonance imaging (MRI) experiments showed similar findings (threefold R2 relaxivity). Confocal fluorescence microscopy localized the αGPC3 NPs only to the cell surface of GPC3-expressing Hep G2 cells. Further characterization of this construct demonstrated a negatively charged, monodisperse, 50 nm NP, ideally suited for tumor targeting. This GPC3-specific NP system, with dual-modality imaging capability, may enhance pretreatment MRI, enable refined intraoperative HCC visualization by near-infrared fluorescence, and be potentially used as a carrier for delivery of tumor-targeted therapies, improving patient outcomes.",
author = "Park, {James O.} and Zachary Stephen and Conroy Sun and Omid Veiseh and Kievit, {Forrest M.} and Chen Fang and Matthew Leung and Hyejung Mok and Miqin Zhang",
year = "2011",
month = "1",
day = "1",
doi = "10.2310/7290.2010.00048",
language = "English (US)",
volume = "10",
pages = "69--77",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "1",

}

TY - JOUR

T1 - Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles

AU - Park, James O.

AU - Stephen, Zachary

AU - Sun, Conroy

AU - Veiseh, Omid

AU - Kievit, Forrest M.

AU - Fang, Chen

AU - Leung, Matthew

AU - Mok, Hyejung

AU - Zhang, Miqin

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Imaging is essential in accurately detecting, staging, and treating primary liver cancer (hepatocellular carcinoma [HCC]), one of the most prevalent and lethal malignancies. We developed a novel multifunctional nanoparticle (NP) specifically targeting glypican-3 (GPC3), a proteoglycan implicated in promotion of cell growth that is overexpressed in most HCCs. Quantitative real-time polymerase chain reaction was performed to confirm the differential GPC3 expression in two human HCC cells, Hep G2 (high) and HLF (negligible). These cells were treated with biotin-conjugated GPC3 monoclonal antibody (αGPC3) and subsequently targeted using superparamagnetic iron oxide NPs conjugated to streptavidin and Alexa Fluor 647. Flow cytometry demonstrated that only GPC3-expressing Hep G2 cells were specifically targeted using this αGPC3-NP conjugate (fourfold mean fluorescence over nontargeted NP), and magnetic resonance imaging (MRI) experiments showed similar findings (threefold R2 relaxivity). Confocal fluorescence microscopy localized the αGPC3 NPs only to the cell surface of GPC3-expressing Hep G2 cells. Further characterization of this construct demonstrated a negatively charged, monodisperse, 50 nm NP, ideally suited for tumor targeting. This GPC3-specific NP system, with dual-modality imaging capability, may enhance pretreatment MRI, enable refined intraoperative HCC visualization by near-infrared fluorescence, and be potentially used as a carrier for delivery of tumor-targeted therapies, improving patient outcomes.

AB - Imaging is essential in accurately detecting, staging, and treating primary liver cancer (hepatocellular carcinoma [HCC]), one of the most prevalent and lethal malignancies. We developed a novel multifunctional nanoparticle (NP) specifically targeting glypican-3 (GPC3), a proteoglycan implicated in promotion of cell growth that is overexpressed in most HCCs. Quantitative real-time polymerase chain reaction was performed to confirm the differential GPC3 expression in two human HCC cells, Hep G2 (high) and HLF (negligible). These cells were treated with biotin-conjugated GPC3 monoclonal antibody (αGPC3) and subsequently targeted using superparamagnetic iron oxide NPs conjugated to streptavidin and Alexa Fluor 647. Flow cytometry demonstrated that only GPC3-expressing Hep G2 cells were specifically targeted using this αGPC3-NP conjugate (fourfold mean fluorescence over nontargeted NP), and magnetic resonance imaging (MRI) experiments showed similar findings (threefold R2 relaxivity). Confocal fluorescence microscopy localized the αGPC3 NPs only to the cell surface of GPC3-expressing Hep G2 cells. Further characterization of this construct demonstrated a negatively charged, monodisperse, 50 nm NP, ideally suited for tumor targeting. This GPC3-specific NP system, with dual-modality imaging capability, may enhance pretreatment MRI, enable refined intraoperative HCC visualization by near-infrared fluorescence, and be potentially used as a carrier for delivery of tumor-targeted therapies, improving patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=79951917796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951917796&partnerID=8YFLogxK

U2 - 10.2310/7290.2010.00048

DO - 10.2310/7290.2010.00048

M3 - Article

C2 - 21303616

AN - SCOPUS:79951917796

VL - 10

SP - 69

EP - 77

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

IS - 1

ER -